Could a common antibiotic help shorten hospital stays for lung fibrosis patients?

NCT ID NCT05842681

Recruiting now Disease control Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Dec 10, 2025 · Last updated May 08, 2026 · Updated 17 times

Summary

This study tests whether adding the antibiotic azithromycin to usual care can help people hospitalized with a sudden worsening of idiopathic pulmonary fibrosis (IPF). About 30 adults with mild to moderate IPF will be randomly assigned to receive either azithromycin plus standard treatment or standard treatment alone. The main goal is to see if the antibiotic shortens hospital stays and improves breathing and recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Assiut university-Faculty of Medicine
RECRUITING

Asyut, 71515, Egypt

Contact Phone: •••-•••-•••• Email: •••••@•••••
Faculty of Medicine Assuit University
ACTIVE_NOT_RECRUITING

Asyut, Egypt

Conditions

Explore the condition pages connected to this study.

IDIOPATHIC PULMONARY FIBROSIS